Apyx Medical Corporation

NasdaqGS:APYX 株式レポート

時価総額:US$41.6m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Apyx Medical マネジメント

マネジメント 基準チェック /34

Apyx Medical'sの CEO はCharlie Goodwinで、 Dec2017年に任命され、 の在任期間は 6.5年です。 の年間総報酬は$ 1.26Mで、 38.2%給与と61.8%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.26%を直接所有しており、その価値は$ 130.50K 。経営陣と取締役会の平均在任期間はそれぞれ5.4年と6.4年です。

主要情報

Charlie Goodwin

最高経営責任者

US$1.3m

報酬総額

CEO給与比率38.2%
CEO在任期間6.8yrs
CEOの所有権0.3%
経営陣の平均在職期間5.7yrs
取締役会の平均在任期間6.6yrs

経営陣の近況

We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Aug 01
We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Recent updates

Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?

Sep 14
Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?

Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Aug 07
Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Aug 01
We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed

Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Jun 19
Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apr 18
Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Mar 26
Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Feb 16
Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Sep 14
Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Jun 07
Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Mar 21
Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

Dec 14
Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Aug 30
We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M

Aug 11

Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin

Jul 18

CEO報酬分析

Apyx Medical の収益と比較して、Charlie Goodwin の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$23m

Dec 31 2023US$1mUS$483k

-US$19m

Sep 30 2023n/an/a

-US$15m

Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$21m

Dec 31 2022US$2mUS$483k

-US$23m

Sep 30 2022n/an/a

-US$19m

Jun 30 2022n/an/a

-US$18m

Mar 31 2022n/an/a

-US$16m

Dec 31 2021US$2mUS$450k

-US$15m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

-US$14m

Mar 31 2021n/an/a

-US$15m

Dec 31 2020US$2mUS$450k

-US$12m

Sep 30 2020n/an/a

-US$16m

Jun 30 2020n/an/a

-US$16m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$2mUS$450k

-US$20m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$15m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$1mUS$400k

-US$11m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$12m

Mar 31 2018n/an/a

-US$15m

Dec 31 2017US$2mUS$15k

-US$14m

報酬と市場: Charlieの 総報酬 ($USD 1.26M ) は、 US市場 ($USD 680.04K ) の同規模の企業の平均を上回っています。

報酬と収益: Charlieの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Charlie Goodwin (58 yo)

6.8yrs

在職期間

US$1,261,470

報酬

Mr. Charles D. Goodwin II, also known as Charlie, has been Chief Executive Officer and Director of Apyx Medical Corporation (formerly known as Bovie Medical Corporation) since December 15, 2017 and serves...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Charles Goodwin
President6.8yrsUS$1.26m0.26%
$ 108.0k
Matthew Hill
CFO, Treasurer & Secretaryless than a yearUS$445.95k0.023%
$ 9.4k
Moshe Citronowicz
Senior Vice President12.7yrsUS$538.31k1.32%
$ 547.8k
Todd Hornsby
Executive Vice President5.7yrsUS$746.27k0%
$ 0
Stavros Vizirgianakis
Executive Chairmanless than a yearデータなし5.04%
$ 2.1m

5.7yrs

平均在職期間

55yo

平均年齢

経験豊富な経営陣: APYXの経営陣は経験豊富で経験豊富です(平均在職期間は5.4年)。


取締役

名称ポジション在職期間報酬所有権
Charles Goodwin
President6.8yrsUS$1.26m0.26%
$ 108.0k
Stavros Vizirgianakis
Executive Chairmanless than a yearデータなし5.04%
$ 2.1m
Michael Geraghty
Independent Director13.5yrsUS$114.06k0.079%
$ 33.0k
Lawrence Waldman
Lead Independent Director13.5yrsUS$162.56k0.12%
$ 51.5k
Brian Kinney
Member of Medical Advisory Board5.2yrsデータなしデータなし
Gregory Konesky
Member of Scientific Advisory Boardno dataUS$9.30kデータなし
Yuval Carmel
Member of Scientific Advisory Boardno dataデータなしデータなし
John C. Andres
Independent Vice-Chairman of the Board10.2yrsUS$144.06k0%
$ 0
Minnie Baylor-Henry
Independent Director5.1yrsUS$116.56k0%
$ 0
Craig Swandal
Independent Director6.5yrsUS$106.56k0.22%
$ 92.6k
Dennis Chi
Member of Medical Advisory Board7.7yrsデータなしデータなし
Diane Duncan
Member of Medical Advisory Board6.3yrsデータなしデータなし

6.6yrs

平均在職期間

68yo

平均年齢

経験豊富なボード: APYXの 取締役会経験豊富 であると考えられます ( 6.4年の平均在任期間)。